156 related articles for article (PubMed ID: 30384610)
1. Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition.
Cai H; Zhang RS; Orwenyo J; Giddens J; Yang Q; LaBranche CC; Montefiori DC; Wang LX
J Med Chem; 2018 Nov; 61(22):10116-10125. PubMed ID: 30384610
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses.
Cai H; Orwenyo J; Giddens JP; Yang Q; Zhang R; LaBranche CC; Montefiori DC; Wang LX
Cell Chem Biol; 2017 Dec; 24(12):1513-1522.e4. PubMed ID: 29107699
[TBL] [Abstract][Full Text] [Related]
3. Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies.
Orwenyo J; Cai H; Giddens J; Amin MN; Toonstra C; Wang LX
ACS Chem Biol; 2017 Jun; 12(6):1566-1575. PubMed ID: 28414420
[TBL] [Abstract][Full Text] [Related]
4. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.
Alam SM; Aussedat B; Vohra Y; Meyerhoff RR; Cale EM; Walkowicz WE; Radakovich NA; Anasti K; Armand L; Parks R; Sutherland L; Scearce R; Joyce MG; Pancera M; Druz A; Georgiev IS; Von Holle T; Eaton A; Fox C; Reed SG; Louder M; Bailer RT; Morris L; Abdool-Karim SS; Cohen M; Liao HX; Montefiori DC; Park PK; Fernández-Tejada A; Wiehe K; Santra S; Kepler TB; Saunders KO; Sodroski J; Kwong PD; Mascola JR; Bonsignori M; Moody MA; Danishefsky S; Haynes BF
Sci Transl Med; 2017 Mar; 9(381):. PubMed ID: 28298421
[TBL] [Abstract][Full Text] [Related]
5. Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV.
Sok D; Doores KJ; Briney B; Le KM; Saye-Francisco KL; Ramos A; Kulp DW; Julien JP; Menis S; Wickramasinghe L; Seaman MS; Schief WR; Wilson IA; Poignard P; Burton DR
Sci Transl Med; 2014 May; 6(236):236ra63. PubMed ID: 24828077
[TBL] [Abstract][Full Text] [Related]
6. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.
Doores KJ; Kong L; Krumm SA; Le KM; Sok D; Laserson U; Garces F; Poignard P; Wilson IA; Burton DR
J Virol; 2015 Jan; 89(2):1105-18. PubMed ID: 25378488
[TBL] [Abstract][Full Text] [Related]
7. Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine.
Cai H; Zhang R; Orwenyo J; Giddens J; Yang Q; LaBranche CC; Montefiori DC; Wang LX
ACS Cent Sci; 2018 May; 4(5):582-589. PubMed ID: 29806004
[TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain.
Li H; Li B; Song H; Breydo L; Baskakov IV; Wang LX
J Org Chem; 2005 Nov; 70(24):9990-6. PubMed ID: 16292832
[TBL] [Abstract][Full Text] [Related]
9. Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.
Longo NS; Sutton MS; Shiakolas AR; Guenaga J; Jarosinski MC; Georgiev IS; McKee K; Bailer RT; Louder MK; O'Dell S; Connors M; Wyatt RT; Mascola JR; Doria-Rose NA
J Virol; 2016 Dec; 90(23):10574-10586. PubMed ID: 27654288
[TBL] [Abstract][Full Text] [Related]
10. Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies.
Amin MN; McLellan JS; Huang W; Orwenyo J; Burton DR; Koff WC; Kwong PD; Wang LX
Nat Chem Biol; 2013 Aug; 9(8):521-6. PubMed ID: 23831758
[TBL] [Abstract][Full Text] [Related]
11. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope.
Barnes CO; Gristick HB; Freund NT; Escolano A; Lyubimov AY; Hartweger H; West AP; Cohen AE; Nussenzweig MC; Bjorkman PJ
Nat Commun; 2018 Mar; 9(1):1251. PubMed ID: 29593217
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
[TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatic Synthesis of HIV-1 Glycopeptide Antigens.
Zong G; Li C; Wang LX
Methods Mol Biol; 2020; 2103():249-262. PubMed ID: 31879931
[TBL] [Abstract][Full Text] [Related]
15. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies.
Krumm SA; Mohammed H; Le KM; Crispin M; Wrin T; Poignard P; Burton DR; Doores KJ
Retrovirology; 2016 Feb; 13():8. PubMed ID: 26837192
[TBL] [Abstract][Full Text] [Related]
17. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.
Nguyen DN; Redman RL; Horiya S; Bailey JK; Xu B; Stanfield RL; Temme JS; LaBranche CC; Wang S; Rodal AA; Montefiori DC; Wilson IA; Krauss IJ
ACS Chem Biol; 2020 Mar; 15(3):789-798. PubMed ID: 32109354
[TBL] [Abstract][Full Text] [Related]
19. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
Fischer K; Nguyen K; LiWang PJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
[TBL] [Abstract][Full Text] [Related]
20. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
